IA
KYMR icon

IFP Advisors’s Kymera Therapeutics KYMR Stock Holding History

IFP Advisors’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.1K Buy
219
+22
+11% +$1.89K ﹤0.01% 2836
2026
Q1 		$16.4K Buy
197
+12
+6% +$950 ﹤0.01% 2880
2025
Q4 		$14.4K Hold
185
– – ﹤0.01% 2885
2025
Q3 		$10.5K Buy
185
+116
+168% +$5.23K ﹤0.01% 2882
2025
Q2 		$13.1K Buy
+69
New +$2.38K ﹤0.01% 2767
2025
Q1 		– Hold
0
– – – 3915
2024
Q4 		– Hold
0
– – – 3965

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

IFP Advisors's KYMR Position: Q2 2026 in Review

IFP Advisors increased its Kymera Therapeutics (KYMR) stake by 11% in Q2 2026, buying an estimated $1.89K and bringing the position to 219 shares worth $25.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2836.

IFP Advisors first reported a position in KYMR in Q2 2025 and has held it in 5 quarters since. 276 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • IFP Advisors held 219 shares of Kymera Therapeutics worth $25.1K as of Q2 2026.
  • IFP Advisors bought 22 Kymera Therapeutics shares in Q2 2026, an estimated $1.89K.
  • Kymera Therapeutics made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #2836 holding.
  • IFP Advisors first reported a position in Kymera Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 276 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.